Citadel Advisors
NSPRW

Citadel Advisors’s InspireMD, Inc. Warrants NSPRW Stock Holding History

Citadel Advisors’s Portfolio NSPRW Stock Details NSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,405
Closed -$3K – 14893
2021
Q1 		$3K Sell
24,405
-60,222
-71% -$8.52K ﹤0.01% 13101
2020
Q4 		$3K Buy
84,627
+68,575
+427% +$1.88K ﹤0.01% 10837
2020
Q3 		$0 Buy
+16,052
New +$234 ﹤0.01% 11054

Other funds holding NSPRW

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors's NSPRW Position: Q2 2021 in Review

Citadel Advisors sold out of InspireMD, Inc. Warrants (NSPRW) in Q2 2021, closing a stake of 24,405 shares — an estimated $3K sold.

Citadel Advisors first reported a position in NSPRW in Q3 2020 and held it in 3 quarters. The position peaked at $3K in Q1 2021. 3 funds tracked by Wall St. Rank hold NSPRW as of Q2 2021.

  • Citadel Advisors reported no remaining InspireMD, Inc. Warrants position as of Q2 2021 after selling out during the quarter.
  • Citadel Advisors sold 24,405 InspireMD, Inc. Warrants shares in Q2 2021, an estimated $3K.
  • Citadel Advisors first reported a position in InspireMD, Inc. Warrants in Q3 2020 and held it in 3 quarters.
  • Citadel Advisors's InspireMD, Inc. Warrants position peaked at $3K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held InspireMD, Inc. Warrants as of Q2 2021.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.